{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:14:37Z","timestamp":1782476077683,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.phrs.2016.07.040","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T17:03:39Z","timestamp":1469725419000},"page":"749-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Targeting the transsulfuration-H 2 S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-4222","authenticated-orcid":false,"given":"Stefano","family":"Fiorucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Distrutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9930","key":"10.1016\/j.phrs.2016.07.040_bib0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2016.07.040_bib0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J. Hepatol."},{"issue":"June (15)","key":"10.1016\/j.phrs.2016.07.040_bib0015","article-title":"Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the Multiethnic Cohort","author":"Setiawan","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.phrs.2016.07.040_bib0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","article-title":"Management of varices and variceal hemorrhage in cirrhosis","volume":"362","author":"Garcia-Tsao","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.040_bib0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2016.07.040_bib0030","doi-asserted-by":"crossref","first-page":"G757","DOI":"10.1152\/ajpgi.00017.2004","article-title":"Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation","volume":"287","author":"DeLeve","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2016.07.040_bib0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(63)80130-4","article-title":"Capillarization of hepatic sinusoids in man","volume":"44","author":"Schaffner","year":"1963","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","author":"Garcia-Pagan","year":"2012","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.040_bib0045","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/hep.27376","article-title":"Liver sinusoidal endothelial cells in hepatic fibrosis","volume":"61","author":"DeLeve","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2016.07.040_bib0050","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","article-title":"Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights","volume":"51","author":"Greuter","year":"2016","journal-title":"J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.phrs.2016.07.040_bib0055","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1172\/JCI119842","article-title":"Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids","volume":"100","author":"Shah","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-6147(02)00049-4","article-title":"Endothelial nitric oxide synthase: the Cinderella of inflammation?","volume":"24","author":"Cirino","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.040_bib0065","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0016-5085(99)70408-7","article-title":"Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat","volume":"117","author":"Shah","year":"1999","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.phrs.2016.07.040_bib0070","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.22351","article-title":"Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence","volume":"48","author":"DeLeve","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2016.07.040_bib0075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","article-title":"Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats","volume":"142","author":"Xie","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2016.07.040_bib0080","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0168-8278(03)00393-3","article-title":"NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver","volume":"39","author":"Fiorucci","year":"2003","journal-title":"J. Hepatol."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2016.07.040_bib0085","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S1590-8658(03)00053-7","article-title":"Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver","volume":"35","author":"Fiorucci","year":"2003","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0090","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol. Rev."},{"issue":"5901","key":"10.1016\/j.phrs.2016.07.040_bib0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1126\/science.1162667","article-title":"H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase","volume":"322","author":"Yang","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.phrs.2016.07.040_bib0100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev.nutr.24.012003.132418","article-title":"Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine","volume":"24","author":"Stipanuk","year":"2004","journal-title":"Annu. Rev. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/187152811794776286","article-title":"Hydrogen sulfide generation in mammals: the molecular biology of cystathionine-\u03b2- synthase (CBS) and cystathionine-\u03b3-lyase (CSE)","volume":"10","author":"Renga","year":"2016","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"11","key":"10.1016\/j.phrs.2016.07.040_bib0110","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbapap.2011.03.006","article-title":"The enzymes of the transsulfuration pathways: active-site characterizations","volume":"1814","author":"Aitken","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"Pt. 1","key":"10.1016\/j.phrs.2016.07.040_bib0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20040243","article-title":"Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression","volume":"381","author":"Ishii","year":"2004","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.040_bib0120","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2015.01.045","article-title":"Interactions between nuclear receptor SHP and FOXA1 maintain oscillatory homocysteine homeostasis in mice","volume":"148","author":"Tsuchiya","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2016.07.040_bib0125","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0016-5085(81)90489-3","article-title":"Evidence for impairment of transsulfuration pathway in cirrhosis","volume":"81","author":"Horowitz","year":"1981","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2016.07.040_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.1840160125","article-title":"Defective methionine metabolism in cirrhosis: relation to severity of liver disease","volume":"16","author":"Marchesini","year":"1992","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2016.07.040_bib0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2310\/6650.2001.33897","article-title":"Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease","volume":"49","author":"Ben-Ari","year":"2001","journal-title":"J. Invest. Med."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.040_bib0140","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1053\/j.gastro.2005.02.034","article-title":"Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver","volume":"128","author":"Robert","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2016.07.040_bib0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2006.07.028","article-title":"Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice","volume":"46","author":"Hamelet","year":"2007","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0150","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.22037","article-title":"The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats","volume":"47","author":"Distrutti","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2016.07.040_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000437098","article-title":"Homocysteine-induced endothelial dysfunction","volume":"67","author":"Lai","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.phrs.2016.07.040_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.nutr.19.1.217","article-title":"Homocysteine metabolism","volume":"19","author":"Selhub","year":"1999","journal-title":"Annu. Rev. Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2016.07.040_bib0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.gastro.2006.02.033","article-title":"The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver","volume":"131","author":"Fiorucci","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.phrs.2016.07.040_bib0170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hep.20817","article-title":"The third gas: h2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis","volume":"42","author":"Fiorucci","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phrs.2016.07.040_bib0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SHK.0b013e3182252ee7","article-title":"The liver as a central regulator of hydrogen sulfide","volume":"36","author":"Norris","year":"2011","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0180","doi-asserted-by":"crossref","first-page":"H801","DOI":"10.1152\/ajpheart.00377.2008","article-title":"Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling","volume":"295","author":"Jha","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2016.07.040_bib0185","doi-asserted-by":"crossref","first-page":"e25943","DOI":"10.1371\/journal.pone.0025943","article-title":"Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity: liver cirrhosis and portal hypertension in rats","volume":"6","author":"Tan","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5085(98)70487-1","article-title":"Reduced nitric oxide production by endothelial cells in cirrhotic rat livers: endothelial dysfunction in portal hypertension","volume":"114","author":"Rockey","year":"1998","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phrs.2016.07.040_bib0195","doi-asserted-by":"crossref","first-page":"G1070","DOI":"10.1152\/ajpgi.00395.2012","article-title":"Hydrogen sulfide modulates sinusoidal constriction and contributes to hepatic microcirculatory dysfunction during endotoxemia","volume":"304","author":"Norris","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"21","key":"10.1016\/j.phrs.2016.07.040_bib0200","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1093\/emboj\/20.21.6008","article-title":"The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener","volume":"20","author":"Zhao","year":"2001","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.phrs.2016.07.040_bib0205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3748\/wjg.v20.i4.1079","article-title":"Role of hydrogen sulfide in portal hypertension and esophagogastric junction vascular disease","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.phrs.2016.07.040_bib0210","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.phrs.2016.07.040_bib0215","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2016.07.040_bib0220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesisl","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"issue":"5418","key":"10.1016\/j.phrs.2016.07.040_bib0225","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1124\/mol.65.2.292","article-title":"A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification","volume":"65","author":"Saini","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.040_bib0235","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.phrs.2016.07.040_bib0240","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0039-128X(00)00127-6","article-title":"Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs","volume":"65","author":"Song","year":"2000","journal-title":"Steroids"},{"issue":"5571","key":"10.1016\/j.phrs.2016.07.040_bib0245","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.phrs.2016.07.040_bib0250","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G rotein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"81","key":"10.1016\/j.phrs.2016.07.040_bib0255","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2005.01.139","article-title":"Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1","volume":"329","author":"Katsuma","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2016.07.040_bib0260","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.molmed.2015.09.001","article-title":"Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders","volume":"21","author":"Fiorucci","year":"2015","journal-title":"Trends Mol. Med."},{"issue":"17","key":"10.1016\/j.phrs.2016.07.040_bib0265","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3748\/wjg.15.2097","article-title":"Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation","volume":"15","author":"Renga","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.phrs.2016.07.040_bib0270","doi-asserted-by":"crossref","first-page":"e0141082","DOI":"10.1371\/journal.pone.0141082","article-title":"Reversal of endothelial dysfunction by GPBAR1 agonism in portal hypertension involves a AKT\/FOXOA1 dependent regulation of H2S generation and endothelin-1","volume":"10","author":"Renga","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2016.07.040_bib0275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jhep.2014.08.024","article-title":"Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension","volume":"62","author":"Mookerjee","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2016.07.040_bib0280","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2016.07.040_bib0285","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cvr\/cvm016","article-title":"FXR-mediated regulation of eNOS expression in vascular endothelial cells","volume":"77","author":"Li","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.07.040_bib0290","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.21458","article-title":"The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells","volume":"43","author":"Keitel","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2016.07.040_bib0295","doi-asserted-by":"crossref","first-page":"H114","DOI":"10.1152\/ajpheart.00087.2015","article-title":"Cystationine \u03b3-liase, a H2S generating enzyme, is a GPBAR1 regulated gene and contribute to vasodilation caused by secondary bile acids","volume":"309","author":"Renga","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2016.07.040_bib0300","first-page":"925350","article-title":"FOXO transcription factors: their clinical significance and regulation","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.phrs.2016.07.040_bib0305","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/mol.64.4.923","article-title":"Role for nuclear factor-kappaB and signal transducer and activator of transcription 1\/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells","volume":"64","author":"Woods","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2016.07.040_bib0310","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"Kida","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2016.07.040_bib0315","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"issue":"7075","key":"10.1016\/j.phrs.2016.07.040_bib0320","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2016.07.040_bib0325","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/138955711796355258","article-title":"Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA","volume":"11","author":"Fiorucci","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"issue":"9972","key":"10.1016\/j.phrs.2016.07.040_bib0330","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"NASH Clinical Research Network, Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816306272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816306272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T18:04:30Z","timestamp":1568225070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816306272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":66,"alternative-id":["S1043661816306272"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.07.040","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.07.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}